Burning Rock Biotech Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Burning Rock Biotech Limited generated cash of -$255,783,000, which is more than the previous year. Cash used in financing activities reached the amount of -$48,832,000 last year. Net change in cash is therefore -$310,052,000.
Cash Flow
| 2017 | -133.70M | -191.07M | 354.16M |
|---|---|---|---|
| 2018 | -148.78M | 106.09M | 83.39M |
| 2019 | -228.04M | -346.66M | 571.73M |
| 2020 | -73.54M | -109.31M | 2.16B |
| 2021 | -477.88M | 81.69M | -52.89M |
| 2022 | -456.80M | -7.46M | -86.23M |
| 2023 | -255.78M | -9.3M | -48.83M |
BNR Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 925.26M | 1.43B | 1.92B | 98.24M | 95.33M | 54.78M | 36.80M |
Operating activities | |||||||
Net income | -653.68M | -971.23M | -796.69M | -407.23M | -169.15M | -177.49M | -131.27M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 133.4M | 124.09M | 47.76M | 33.30M | 31.35M | 24.67M | 21.31M |
Stock-based compensation expense | 260.71M | 326.78M | 282.43M | 173.22M | 22.79M | 0 | 4.05M |
| Deferred income tax benefit | 260.71M | 326.78M | 282.43M | 173.22M | 22.79M | 0 | 4.05M |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | -12.38M | -21.50M | -18.93M | -13.04M | -65.94M | 4.16M | -31.16M |
Inventories | 57.27M | 11.20M | -66.99M | -9.44M | -8.12M | -32.25M | -489K |
Accounts payable | -31.12M | 16.63M | -5.10M | 25.84M | -3.32M | 2.20M | 9.57M |
Cash generated by operating activities | -255.78M | -456.80M | -477.88M | -73.54M | -228.04M | -148.78M | -133.70M |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | -63.92M | -348.42M | -408.62M | 0 | -165.70M |
Investments In Property Plant And Equipment | -8.10M | -62.03M | -213.44M | -79.53M | -45.73M | -24.71M | -23.01M |
Acquisitions Net | 0 | 0 | 2.52M | 3.96M | 401K | 0 | -2.37M |
Cash generated by investing activities | -9.3M | -7.46M | 81.69M | -109.31M | -346.66M | 106.09M | -191.07M |
Financing activities | |||||||
Common Stock Issued | 0 | 0 | 0 | 1.85B | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -6.97M | -71.83M | -4.27M | -3.5M | -3.63M | -1.5M | -9.06M |
Repayments of term debt | 0 | -2.37M | -44.80M | -43.80M | -81.59M | -13.71M | 11.45M |
Cash used in financing activities | -48.83M | -86.23M | -52.89M | 2.16B | 571.73M | 83.39M | 354.16M |
Net Change In Cash | -310.05M | -513.84M | -486.09M | 1.82B | 2.91M | 40.54M | 17.98M |
Cash at end of period | 615.21M | 925.26M | 1.43B | 1.92B | 98.24M | 95.33M | 54.78M |
| Data source | Data source | Data source | Data source |